Resistance in Vancomycin-Resistant Enterococci

William R Miller1, Barbara E Murray2, Louis B Rice3

  • 1Department of Internal Medicine, Division of Infectious Diseases, University of Texas Health Science Center at Houston, McGovern Medical School, 6431 Fannin St. MSB 2.112, Houston, TX 77030, USA; Center for Antimicrobial Resistance and Microbial Genomics (CARMiG).

Insights

Serious infections from vancomycin-resistant enterococci (VRE) remain challenging despite new antibiotics. Understanding resistance emergence and colonization is key for better clinical management of these difficult hospital-associated pathogens.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Serious infections caused by vancomycin-resistant enterococci (VRE) present significant clinical challenges.
  • Treatment often requires combination therapy and careful management of toxicity.
  • Despite new antibiotic options, VRE infections remain difficult to treat.

Purpose of the Study:

  • To highlight the persistent challenges in managing vancomycin-resistant enterococci infections.
  • To emphasize the need for a deeper understanding of VRE resistance and colonization.
  • To prepare clinicians for tackling these hospital-associated pathogens more effectively.

Main Methods:

  • Review of current literature on vancomycin-resistant enterococci.
  • Analysis of factors contributing to resistance emergence.
  • Examination of gastrointestinal colonization dynamics and microbiota-mediated resistance.
  • Investigation of resistance mechanisms against available therapeutics.

Main Results:

  • Vancomycin-resistant enterococci infections continue to be a major clinical concern.
  • New antibiotics have been introduced, but significant therapeutic challenges persist.
  • Understanding resistance drivers and colonization is crucial for effective treatment.

Conclusions:

  • A comprehensive understanding of VRE resistance mechanisms and colonization is essential.
  • This knowledge will better equip clinicians to manage VRE infections.
  • Improved preparedness is vital for combating these challenging hospital-associated pathogens.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
853
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
802
Antibiotic Selection00:57

Antibiotic Selection

Overview
58.1K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
182
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
108